Last reviewed · How we verify

Macrogol 3350 plus ascorbic acid

Fundación Canaria Rafael Clavijo para la Investigación Biomédica · FDA-approved active Small molecule

Macrogol 3350 plus ascorbic acid is an osmotic laxative bowel preparation that draws water into the intestinal lumen to promote evacuation, with ascorbic acid enhancing tolerability and reducing volume requirements.

Macrogol 3350 plus ascorbic acid is an osmotic laxative bowel preparation that draws water into the intestinal lumen to promote bowel evacuation. Used for Bowel cleansing prior to colonoscopy or other gastrointestinal procedures.

At a glance

Generic nameMacrogol 3350 plus ascorbic acid
SponsorFundación Canaria Rafael Clavijo para la Investigación Biomédica
Drug classOsmotic laxative bowel preparation
ModalitySmall molecule
Therapeutic areaGastroenterology
PhaseFDA-approved

Mechanism of action

Macrogol 3350 (polyethylene glycol) is a non-absorbable osmotic agent that creates an osmotic gradient in the bowel, drawing fluid into the intestinal lumen and promoting bowel movement without systemic absorption. Ascorbic acid (vitamin C) is added to improve palatability and reduce the total volume of solution needed while maintaining efficacy for bowel cleansing prior to colonoscopy or other procedures.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: